Dr. Sharpless succeeds H. Shelton “Shelley” Earp, MD, as center director. Dr. Earp will continue as director of UNC Cancer Care, a role in which he coordinates cancer care and research across the School of Medicine, the University and UNC Health Care System.
The research team included Dr. Paul Godley of the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center.
This study shows that cell mobility occurs through the interactions between the protein vinculin and the cytoskeletal lattice formed by the protein actin.
The laboratory has provided an invaluable service to patients and has also built capacity at a national teaching hospital, according to an analysis of the first 20 months of operation published online by PLOS ONE.
RNA diagnostic test from paraffin improves lung cancer diagnosis over routine microscopic evaluation alone
Scientists at the Universities of North Carolina and Utah have developed a histology expression predictor for the most common types of lung cancer: adenocarcinoma, carcinoid, small cell carcinoma and squamous cell carcinoma.
A 65-year-old Person County man is successfully treated for a rare head and neck cancer, but the treatment side effects damaged his teeth and gums. He may have lost his pearly whites, but not his spirit or his faith.
Scientists found that among white women, household size and losing a job due to one's diagnosis were reasons for delay in treatment, while among African-American women, the type of treatment received influenced delay.
About half of the obstetrician-gynecologists surveyed in a recent study said they continue to provide annual exams. Drs. Russell Harris and Stacey Sheridan of UNC say this is an outdated practice that may be more harmful than helpful.
New evidence by a UNC-led team shows that MerTK macrophage action in the microenvironment that surrounds cancer cells blunts the immune response, allowing the tumor cell to grow and metastasize.
A UNC research team found that genetically engineered mouse models (GEMMs) were able to accurately predict human response to a standard chemotherapy drug combination commonly used in the clinic.
Dr. Ethan Basch of UNC calls for pharmaceutical manufacturers to collect rigorous information on how drugs impact symptoms and quality of life starting early in drug development, and for the U.S. Food and Drug Administration (FDA) to include this information in drug labels.
A team of scientists from the University of North Carolina School of Medicine, North Carolina State University’s College of Veterinary Medicine and Duke University have conducted one of the first studies to directly compare canine and human B-cell lymphoma by examining molecular similarities and differences between the two species.
Better treatments for people suffering from compromised intestinal immunity may emerge from a small-animal model of human intestinal immune development.
Kathy DeClue of Randolph County was featured in Family House Diaries in August 2012. She celebrated the success of a second stem cell transplant for leukemia by renewing her wedding vows with her husband of 41 years before 80 friends and family.
Clinical geneticist James Evans, MD, PhD helped to open the exhibition, Genome: Unlocking Life's Code. The high-tech, high-intensity display celebrates the 10th anniversary of production of the first complete human genome sequence also known as the genetic blueprint of the human body.
A research team, including UNC scientists, reports that including the positive effect of aspirin on cancer mortality influences the threshold for prescribing aspirin for primary prevention in men.
The study will focus on assessing the impact of a clinic-based intervention that includes having patients view a multimedia decision aid (in English or Spanish) before seeing their physician, as well as support from a bilingual patient “navigator” on completion of recommended colon cancer screening tests.
New research from the UNC School of Medicine has shown how a protein called UHRF1 “reads” the histone code in a specific way to perform an important cellular function.
Are there enough clinical trials data to guide every radiation oncology decision in a cancer patient's care? Not necessarily, according to a UNC School of Medicine study.
A University of North Carolina School of Medicine team offers first evidence of the role of a protein called GSK-3 alpha in promoting oncogenic KRAS function.